NCT00003853View on ClinicalTrials.gov

4'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic Amyloidosis

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

April 30, 1999

Primary Completion Date

August 31, 2000

Study Completion Date

August 31, 2001

Conditions
Multiple Myeloma and Plasma Cell Neoplasm
Interventions
DRUG

4'-iodo-4'-deoxydoxorubicin

Trial Locations (3)

27100

University of Pavia, Pavia

55905

Mayo Clinic Cancer Center, Rochester

72205

University of Arkansas for Medical Sciences, Little Rock

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH